GZMB and neoplasm: No difference in cytotoxic activity between GrB-Ki4(scFv) and its mutant R201K was detected on PI9-negative cells in vitro, but only the mutant was able to kill both PI9-positive and negative tumor cells in vitro as well as in vivo.